[Skip to Content]

Bladder Cancer Program

Bladder Cancer Program
Upstate Specialty Services at Harrison Center
Suite M
550 Harrison Street
Syracuse, NY 13202
Google Maps & Directions
Phone: 315 464-1500

Facts About Bladder Cancer

  • Bladder cancer is one of the most commonly diagnosed cancers, with an estimated 81,190 new cases each year

  • Bladder cancer incidence is about four times higher in men than in women

  • There are over 696,440 bladder cancer survivors in the US

*American Cancer Society

The Bladder Cancer Program at the Upstate Cancer Center is a multidisciplinary team of physicians dedicated to early detection, diagnosis, and treatment of bladder cancer.

There are many effective treatments for bladder cancer at every stage and grade of disease. Low grade tumors can be treated with camera procedures followed by chemotherapy placed inside the bladder. High grade tumors will require more intensive treatment with immunotherapy. Invasive tumors may require removal of the bladder along with chemotherapy. 

Why Choose Upstate

As an academic medical center with many experts who specialize in specific diseases, Upstate has urologists who specialize in the treatment of bladder cancer. This expertise means patients have many treatment options that may not be offered by most local urologists.

For example:

  • Blue Light Enhanced Cystoscopy – Upstate is the only hospital in the region to offer this technology that has been shown in studies to diagnose more tumors and decrease the chance that tumors recur, especially CIS.
  • Neobladder and Continent Urinary Reservoirs – If you have muscle invasive bladder cancer, the standard of care is removal of the bladder. You may be familiar with the stoma procedure to collect urine in an ostomy bag. However, this may not be the best option for you. Surgeons at Upstate can discuss creating a new bladder or a pouch. Both of these options are continent which means they do not require a bag.
  • Clinical Trials – We offer various clinical trials for different stages of disease. Our clinical trials range from immunotherapy for resistant bladder cancer to novel medicines placed inside the bladder to decrease recurrence and preserve your bladder.